Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kavana

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Trends in Pharmacological Sciences|February 29, 2016
Bridging Model-Dependent Receptor Agonism and Allosterism ParameterizationRumin Zhang, Michael Kavana
Expert Opinion on Drug Discovery|May 1, 2015
Quantitative analysis of receptor allosterism and its implication for drug discoveryRumin Zhang, Michael Kavana
Scientific Reports|April 28, 2016
Quantitative Measure of Receptor Agonist and Modulator Equi-Response and Equi-Occupancy SelectivityRumin Zhang, Michael Kavana
Biochemistry|August 27, 2003
Interaction of (4-hydroxyphenyl)pyruvate dioxygenase with the specific inhibitor 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedioneMichael Kavana, Graham R Moran
Journal of the American Chemical Society|April 9, 2004
CD and MCD studies of the non-heme ferrous active site in (4-hydroxyphenyl)pyruvate dioxygenase: correlation between oxygen activation in the extradiol and alpha-KG-dependent dioxygenasesMichael L Neidig, Michael Kavana, Graham R Moran, et al.
Biochemistry|May 11, 2005
Accumulation of multiple intermediates in the catalytic cycle of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilisKayunta Johnson-Winters, Vincent M Purpero, Michael Kavana, et al.
Biochemical and Biophysical Research Communications|October 4, 2005
Spectroscopic and computational studies of NTBC bound to the non-heme iron enzyme (4-hydroxyphenyl)pyruvate dioxygenase: active site contributions to drug inhibitionMichael L Neidig, Andrea Decker, Michael Kavana, et al.
Biochemistry|February 20, 2003
(4-Hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis: the basis for ordered substrate additionKayunta Johnson-Winters, Vincent M Purpero, Michael Kavana, et al.
Frontiers in Bioscience (Scholar Edition)|April 22, 2016
Moderate to high throughput in vitro binding kinetics for drug discoveryRumin Zhang, Christopher M Barbieri, Margarita Garcia-Calvo, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2009
Synthesis and characterization of a BODIPY-labeled derivative of Soraphen A that binds to acetyl-CoA carboxylaseBrian Raymer, Michael Kavana, Allen Price, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Trends in Pharmacological Sciences|February 29, 2016
Bridging Model-Dependent Receptor Agonism and Allosterism ParameterizationRumin Zhang, Michael Kavana
Expert Opinion on Drug Discovery|May 1, 2015
Quantitative analysis of receptor allosterism and its implication for drug discoveryRumin Zhang, Michael Kavana
Scientific Reports|April 28, 2016
Quantitative Measure of Receptor Agonist and Modulator Equi-Response and Equi-Occupancy SelectivityRumin Zhang, Michael Kavana
Biochemistry|August 27, 2003
Interaction of (4-hydroxyphenyl)pyruvate dioxygenase with the specific inhibitor 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedioneMichael Kavana, Graham R Moran
Journal of the American Chemical Society|April 9, 2004
CD and MCD studies of the non-heme ferrous active site in (4-hydroxyphenyl)pyruvate dioxygenase: correlation between oxygen activation in the extradiol and alpha-KG-dependent dioxygenasesMichael L Neidig, Michael Kavana, Graham R Moran, et al.
Biochemistry|May 11, 2005
Accumulation of multiple intermediates in the catalytic cycle of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilisKayunta Johnson-Winters, Vincent M Purpero, Michael Kavana, et al.
Biochemical and Biophysical Research Communications|October 4, 2005
Spectroscopic and computational studies of NTBC bound to the non-heme iron enzyme (4-hydroxyphenyl)pyruvate dioxygenase: active site contributions to drug inhibitionMichael L Neidig, Andrea Decker, Michael Kavana, et al.
Biochemistry|February 20, 2003
(4-Hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis: the basis for ordered substrate additionKayunta Johnson-Winters, Vincent M Purpero, Michael Kavana, et al.
Frontiers in Bioscience (Scholar Edition)|April 22, 2016
Moderate to high throughput in vitro binding kinetics for drug discoveryRumin Zhang, Christopher M Barbieri, Margarita Garcia-Calvo, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2009
Synthesis and characterization of a BODIPY-labeled derivative of Soraphen A that binds to acetyl-CoA carboxylaseBrian Raymer, Michael Kavana, Allen Price, et al.
Pageof 3